Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

UI Health to launch EPIC program to cut frequent ER visits, readmissions to hospital

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Study finds no evidence that digoxin increases mortality in patients with atrial fibrillation

Large numbers of ER visits go unreported in calculating hospital readmission rates

Large numbers of ER visits go unreported in calculating hospital readmission rates

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Researchers develop nanodiamond delivery system for triple-negative breast cancer

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Acorda Therapeutics reports positive data from dalfampridine-ER post-stroke deficits trial

Michigan's first cardio-oncology clinic launched to prevent heart problems

Michigan's first cardio-oncology clinic launched to prevent heart problems

L-carnitine improves cardiac health in patients after heart attack, say researchers

L-carnitine improves cardiac health in patients after heart attack, say researchers

Researchers discover 14 new genetic variations associated with heart rate

Researchers discover 14 new genetic variations associated with heart rate

Death of heart tissue could be prevented with new medicines, say TUSM scientists

Death of heart tissue could be prevented with new medicines, say TUSM scientists

Nearly 8% of patients in VHA visit emergency department two or more times per year: Study

Nearly 8% of patients in VHA visit emergency department two or more times per year: Study

Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

Sorbent Therapeutics starts patient dosing in Phase 2b clinical trial of CLP-1001

Abbott's ARCHITECT Galectin-3 assay earns CE mark

Abbott's ARCHITECT Galectin-3 assay earns CE mark

First-in-humans study introduces next generation cell therapy for heart failure patients

First-in-humans study introduces next generation cell therapy for heart failure patients

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Researchers discover new molecular mechanism to prevent edema formation

Researchers discover new molecular mechanism to prevent edema formation

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Weight loss and heart damage: an interview with Dr Lili Barouch, Johns Hopkins University School of Medicine

Integrated advanced cardiovascular imaging modalities can change cardiac care

Integrated advanced cardiovascular imaging modalities can change cardiac care

Death rates on the rise at some rural hospitals

Death rates on the rise at some rural hospitals

Study finds high mortality rates in rural hospitals

Study finds high mortality rates in rural hospitals

Both black and white Americans have similar, higher lifetime risk of heart failure, study shows

Both black and white Americans have similar, higher lifetime risk of heart failure, study shows

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.